Recursion Pharmaceuticals
Alexa B. has a robust background in drug development and program management, currently serving as the Director of Drug Development, Program Management at Recursion. Previous roles include Independent Consultant at Brown Scientific Consulting, Director of Program Management and Medical Writing at Nuvation Bio, Director of Medical Writing at Portola Pharmaceuticals, and Senior Manager of Medical Writing at Ultragenyx Pharmaceutical Inc. This extensive experience in medical writing and program management showcases expertise in the pharmaceutical industry.
This person is not in any teams
This person is not in any offices
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.